2017
DOI: 10.1002/jcp.26042
|View full text |Cite
|
Sign up to set email alerts
|

The roles of signaling pathways in bone repair and regeneration

Abstract: Regenerative medicine has sparked interest in potential strategies for bone repair. Bone defects are widespread and could be caused by trauma, congenital malformations, infections, and surgery. Although bone has a large self-healing capacity, some defects or fractures are too big to regenerate. To regenerate bone structures which can be used for treatment of patients, bone growth must be induced by a number of bioactive implantable materials, cell types and intracellular, and extracellular molecular signaling … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
220
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 318 publications
(223 citation statements)
references
References 161 publications
(217 reference statements)
1
220
0
2
Order By: Relevance
“…From among three different sources of donor tissues, including heterologous (different species such as bovine), allogeneic (same species, different individual), and autologous (derived from the biopsy of tissue obtained from the host), autologous cells are most preferred due to minimized risk of rejection (Atala, ). However, in some situations such as end‐stage organ failure, where a tissue biopsy may not produce enough cells for expansion, or when there is no possibility of expanding cells from a distinct organ, such as the pancreas, stem cells are being alternative sources (Majidinia, Sadeghpour, & Yousefi, ). In addition, the proliferation capacity of many adult organ‐specific cells is low and long‐term in vitro cultivation, in particular, reduces their functional quality.…”
Section: Regenerative Medicinementioning
confidence: 99%
“…From among three different sources of donor tissues, including heterologous (different species such as bovine), allogeneic (same species, different individual), and autologous (derived from the biopsy of tissue obtained from the host), autologous cells are most preferred due to minimized risk of rejection (Atala, ). However, in some situations such as end‐stage organ failure, where a tissue biopsy may not produce enough cells for expansion, or when there is no possibility of expanding cells from a distinct organ, such as the pancreas, stem cells are being alternative sources (Majidinia, Sadeghpour, & Yousefi, ). In addition, the proliferation capacity of many adult organ‐specific cells is low and long‐term in vitro cultivation, in particular, reduces their functional quality.…”
Section: Regenerative Medicinementioning
confidence: 99%
“…Although the bone has a large self-healing capacity, in some complex clinical conditions, such as large bone defects created by trauma, infection, tumor resection, and skeletal abnormalities, or in cases where bone repair failed, a large quantity of bone regeneration are required [103]. In this case, bone tissue engineering has emerged as a promising alternative to augment insufficient bone repair.…”
Section: Therapeutic Applications Of Pemfs In Bone Repairmentioning
confidence: 99%
“…Bone loss and defective repair mechanisms brought by trauma, osteonecrosis, osteoporosis, arthritis, tumors, and other diseases affecting bone cause severe pain, dyskinesia, psychological agony, and economic burden to patients [1, 2]. Therefore, effective treatment strategy for promoting bone growth and remodeling is needed.…”
Section: Introductionmentioning
confidence: 99%
“…введение костная регенерация является сложным, хо-рошо организованным многоэтапным процессом [1,2], для интенсификации которого необходима активация ранней фазы ангиогенеза за счет экс-прессии тромбоцитарного фактора роста (pdgF) [3]. Было показано, что pdgF совместно с костным морфогенетическим белком 2 (ВМР-2) участвуют в формировании сосудистых трубочек, в миграции мультипотентных мезенхимальных стромальных клеток, а также в их дифференцировке в остео-бласты.…”
unclassified